[go: up one dir, main page]

AR111911A2 - IMMUNOGENIC COMPOSITION THAT INCLUDES AN ADJUSTER FORMULATION, VACCINE COMPOSITION, PROCEDURE, USES, METHODS - Google Patents

IMMUNOGENIC COMPOSITION THAT INCLUDES AN ADJUSTER FORMULATION, VACCINE COMPOSITION, PROCEDURE, USES, METHODS

Info

Publication number
AR111911A2
AR111911A2 ARP180101458A ARP180101458A AR111911A2 AR 111911 A2 AR111911 A2 AR 111911A2 AR P180101458 A ARP180101458 A AR P180101458A AR P180101458 A ARP180101458 A AR P180101458A AR 111911 A2 AR111911 A2 AR 111911A2
Authority
AR
Argentina
Prior art keywords
formulation
vaccine composition
adjuster
procedure
methods
Prior art date
Application number
ARP180101458A
Other languages
Spanish (es)
Original Assignee
Zoetis Services Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc
Publication of AR111911A2 publication Critical patent/AR111911A2/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Reivindicación 1: Una composición de vacuna que comprende un componente de antígeno y una formulación de adyuvante, comprendiendo la formulación de adyuvante una saponina triterpenoide, un esterol, un compuesto de amonio cuaternario y un polímero de ácido poliacrílico, en donde el componente de antígeno comprende Virus de leucemia felina. Reivindicación 3: La composición de vacuna de la reivindicación 1, en la que la saponina es Quil A o una fracción purificada de la misma, el esterol es colesterol, y el compuesto de amonio cuaternario es DDA.Claim 1: A vaccine composition comprising an antigen component and an adjuvant formulation, the adjuvant formulation comprising a triterpenoid saponin, a sterol, a quaternary ammonium compound and a polyacrylic acid polymer, wherein the antigen component comprises Feline Leukemia Virus Claim 3: The vaccine composition of claim 1, wherein the saponin is Quil A or a purified fraction thereof, the sterol is cholesterol, and the quaternary ammonium compound is DDA.

ARP180101458A 2008-06-27 2018-05-31 IMMUNOGENIC COMPOSITION THAT INCLUDES AN ADJUSTER FORMULATION, VACCINE COMPOSITION, PROCEDURE, USES, METHODS AR111911A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7623208P 2008-06-27 2008-06-27

Publications (1)

Publication Number Publication Date
AR111911A2 true AR111911A2 (en) 2019-08-28

Family

ID=52297695

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP180101457A AR111910A2 (en) 2008-06-27 2018-05-31 IMMUNOGENIC COMPOSITION THAT INCLUDES AN ADJUSTER FORMULATION, VACCINE COMPOSITION, PROCEDURE, USES, METHODS
ARP180101458A AR111911A2 (en) 2008-06-27 2018-05-31 IMMUNOGENIC COMPOSITION THAT INCLUDES AN ADJUSTER FORMULATION, VACCINE COMPOSITION, PROCEDURE, USES, METHODS

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP180101457A AR111910A2 (en) 2008-06-27 2018-05-31 IMMUNOGENIC COMPOSITION THAT INCLUDES AN ADJUSTER FORMULATION, VACCINE COMPOSITION, PROCEDURE, USES, METHODS

Country Status (2)

Country Link
AR (2) AR111910A2 (en)
UA (1) UA104138C2 (en)

Also Published As

Publication number Publication date
UA104138C2 (en) 2014-01-10
AR111910A2 (en) 2019-08-28

Similar Documents

Publication Publication Date Title
CL2010001360A1 (en) Immunogenic composition comprising an antigen component and an adjuvant formulation which comprises a saponin, a sterol, a quaternary ammonium compound and a polymer; preparation procedure; and its uses
MX2010008468A (en) NUCLEIC ACIDS COMPRISING FORMULA (NuGlX<sub >mGnNv)a AND DERIVATIVES THEREOF AS AN IMMUNOSTIMULATING AGENTS /ADJUVANTS.
CY1115751T1 (en) PHARMACEUTICAL COMBINATION 3- (3-DIMETHYLAMINO-1-ETHYL-2-METHYLPROPYL) -PHENOLIS AND AN ANTIPEXIL
CL2007001698A1 (en) Immunogenic composition comprising the meningococcal lipooligosaccharides (los) of immunotypes l2 and l3 of neisseric strains; vaccine composition that comprises it; preparation procedure; and its use for the prevention or treatment of diseases caused by one or more serogroups of n. meningitidis
BR112015015031A2 (en) glycoconjugation process
CO6251273A2 (en) COMPOSITIONS FOR EMULSION VACCINE THAT INCLUDE ANTIGEN AND AN ASSISTANT IN THE WATERPROOF PHASE AND ITS METHOD OF ELABORATION
AR036039A1 (en) VACCINE COMPOSITION FOR THE INFLUENZA VIRUS
PE20061300A1 (en) MULTIVALENT IMMUNOGENIC COMPOSITIONS INCLUDING AN ANTIGEN OF THE FLU OR ANTIGENIC PREPARATION IN COMBINATION WITH AN ADJUVANT OF EMULSION OF OIL IN WATER
MX2010008799A (en) Process for stabilizing an adjuvant containing vaccine composition.
EA200701632A1 (en) VACCINE AGAINST WIND SPRAY VIRUS
PE20151588A1 (en) VACCINE AGAINST DENGUE VIRUS
CL2018002692A1 (en) Bivalent vaccine against swine flu virus (divisional application 201701961)
WO2009155489A3 (en) Compositions and methods for treating influenza
DE602005025342D1 (en) VACCINE COMPOSITIONS WITH VIRUSOMES AND A SAPONIN ADJUVANS
BR112015005056A2 (en) combination vaccines with meningococcus serogroup b and d / t / p
EP2078083A4 (en) NEW CANINE INFLUENZA VIRUS AND CORRESPONDING VACCINE
ECSP109984A (en) IMPROVED PHARMACEUTICAL COMPOSITION CONTAINING DIHYDROPIRIDINE, ANTAGONIST OF THE CALCIUM CHANNEL AND THE METHOD FOR PREPARATION
BRPI0907789A2 (en) 16-alpha and 17-alpha derivatives of glucocorticosteroids and their uses
AR108829A1 (en) VACCINE AGAINST INFECTIOUS BRONCHITIS VIRUS
CO6361948A2 (en) USE OF MYCOPLASMA BOVIS ANTIGEN
CO6300963A2 (en) A VACCINE AGAINST THE MALARIA UNDERSTANDING P. FALCIPARUM AND P. VIVAX
WO2011039180A3 (en) Novel vaccine composition against influenza
BR112012014689A2 (en) vaccine composition
AR065765A1 (en) VACCINE COMPOSITION FOR THE TREATMENT OF RESPIRATORY INFECTIOUS DISEASES
AR111911A2 (en) IMMUNOGENIC COMPOSITION THAT INCLUDES AN ADJUSTER FORMULATION, VACCINE COMPOSITION, PROCEDURE, USES, METHODS

Legal Events

Date Code Title Description
FG Grant, registration